Loss-of-function Aspergillus nidulans CclA, a Bre2 ortholog involved in histone H3 lysine 4 methylation, activated the expression of cryptic secondary metabolite clusters in A. nidulans. One new cluster generated monodictyphenone, emodin and emodin derivatives, whereas a second encoded two anti-osteoporosis polyketides, F9775A and F9775B. Modification of the chromatin landscape in fungal secondary metabolite clusters allows for a simple technological means to express silent fungal secondary metabolite gene clusters.
Loss-of-function Aspergillus nidulans CclA, a Bre2 ortholog involved in histone H3 lysine 4 methylation, activated the expression of cryptic secondary metabolite clusters in A. nidulans. One new cluster generated monodictyphenone, emodin and emodin derivatives, whereas a second encoded two anti-osteoporosis polyketides, F9775A and F9775B. Modification of the chromatin landscape in fungal secondary metabolite clusters allows for a simple technological means to express silent fungal secondary metabolite gene clusters.
Aspergilli are ubiquitous filamentous fungi whose members include human and plant pathogens and industrial fungi with tremendous medical, agricultural and biotechnological importance. Although demonstrating synteny along large tracks of their sequenced genomes, members of this genus vary remarkably in their secondary metabolome, possibly reflecting a chemical arsenal important in niche securement 1, 2 . The sheer numbers of unique secondary metabolite (SM) genes highlight the genus as a potentially rich source of bioactive metabolites for medicinal and pharmaceutical use. Gene wealth, however, has not translated well into compound production, in part due to an inability to find conditions promoting expression of SM gene clusters.
Some progress has been achieved in activating SM gene cluster expression using the model organism Aspergillus nidulans. Genome sequence analysis of A. nidulans reveals dozens of putative SM gene clusters including the well-studied penicillin G (1) and sterigmatocystin (2) clusters 3 . Yet, the regulation mechanism of the expression of most SM gene clusters and their concomitant products remains veiled. Two approaches for activating otherwise silent clusters have been recently described. One strategy, using the knowledge that many SM gene clusters contain a pathway-specific transcription factor, involved fusing an inducible promoter to a cluster transcription factor leading to the production of hybrid polyketide-nonribosomal peptide metabolites, the cytotoxic aspyridones A (3) and B (4) 4 . A second approach, based on genomic mining of microarrays generated from mutants of the global regulator of secondary metabolism LaeA 5-7 , led to the identification of the anti-tumor compound terrequinone A (5) 8 . Efforts to uncover the regulatory role of LaeA revealed that some subtelomeric SM gene clusters were located in heterochromatic regions of the genome where suppression was relieved by deletion of a key histone deacetylase 9 . The importance of histone modifications in SM gene clusters was also reflected in the initiation and spread of histone H4 acetylation concurrent with transcriptional activation of the subtelomeric A. parasiticus aflatoxin B1 (6) gene cluster 10 .
A consideration of the accruing evidence linking chromatin modifications with SM gene cluster regulation led us to examine the hypothesis that additional chromatin-modifying proteins were important in SM gene cluster regulation. In particular, we examined a member of the complex associated with Set1 (COMPASS) for possible regulatory roles in SM gene silencing. COMPASS is a conserved eukaryotic transcriptional effector both facilitating and repressing chromatin-mediated processes through methylation of lysine 4 of histone H3 (H3K4) 11, 12 . Although H3K4me2 and H3K4me3 are found predominantly on transcriptionally active loci 12 , COMPASS also regulates homothallic mating silencing, ribosomal DNA silencing, telomere length and subtelomeric gene expression in yeast [13] [14] [15] .
A critical member of COMPASS is the SPRY domain protein designated Bre2 in Saccharomyces cerevisiae 11 . Analysis of the A. nidulans genome revealed a putative ortholog of Bre2, here named CclA. Extracts of cclA deletion mutants (cclAD; Supplementary Methods online), deficient in H3K4 di-and trimethylation ( Fig. 1 and Supplementary Fig. 1 online) , presented an altered chemical landscape as depicted by thin layer chromatography (Supplementary Fig. 2 online) . Previous work has shown the major SM produced by A. nidulans is the polyketide sterigmatocystin. To reduce background amounts of sterigmatocystin and its precursor, we also deleted stcJ, which encodes a fatty acid synthase required for sterigmatocystin production 16 , generating a double stcJD, cclAD mutant. HPLC profiles of stcJD extract showed the presence of two known metabolites of A. nidulans, austinol (7) and dehydroaustinol (8) , and the absence of sterigmatocystin. Analysis of the stcJD, cclAD double mutant yielded at least six additional aromatic compounds. Full oneand two-dimensional NMR analysis revealed the compounds as monodictyphenone (9) , emodin (10) and four other emodin analogs (11, 12, 13 and 14) (Fig. 1a,b) .
Monodictyphenone has been previously isolated from a marine fungus Monodictys putredinis 17 as well as an engineered strain of A. nidulans 18 . This strain of A. nidulans expressed the Glarea lozoyensis polyketide synthase gene involved for 6-methylsalicylic acid (15) biosynthesis, and the authors could not determine whether the monodictyphenone produced in addition to 6-methylsalicylic acid was due © 2009 Nature America, Inc. All rights reserved.
to the heterologous gene or expression of an endogenous A. nidulans PKS2 (ref. 18) . Our data revealed that monodictyphenone is a product of A. nidulans and not derived from the heterologously expressed gene. Monodictyphenone, a metabolite with antimicrobial properties, shares structural similarity to a known A. terreus metabolite sulochrin (16) , which is derived from the anthraquinone emodin 19 . Emodin, not known until now to be produced by A. nidulans, is an active anthraquinone constituent demonstrating anti-mutagenic, anti-cancer, vasorelaxant, immunosuppressive anti-inflammation and anti-apoptosis activities 20 .
Monodictyphenone, and emodin and its derivatives (11) (12) (13) (14) , share a similar aromatic polyketide structure, which suggests that a single nonreduced polyketide synthase is involved in their biosynthesis. We selected 10 of the 12 nonreduced polyketide synthases in A. nidulans for disruption. The two known nonreduced polyketide synthases not targeted were the sterigmatocystin polyketide synthase and the wA polyketide synthase (required for production of a spore pigment). Metabolite analysis of the 10 polyketide synthase mutant strains identified a single polyketide synthase (AN0150, 65.5% identical to the A. terreus emodin anthrone polyketide synthase gene) responsible for production of all compounds 9-14 (Fig. 1b) .
The gene encoding AN0150 is located 0.5 Mb from the right telomere of 5 Mb chromosome VIII and is surrounded by several genes with high homologies to genes found in the sterigmatocystin and aflatoxin gene clusters (Supplementary Table 1 and Supplementary Fig. 3 online) . One of these gene products, AN0148, showed similarity to AflR, a Zn 2 Cys 6 binuclear transcription factor required for expression of enzyme genes in the sterigmatocystin cluster 21 . Replacement of the promoter region of AN0148 with the alcA inducible promoter (Supplementary Tables 2  and 3 online) allowed induction of compounds 9-14 (Supplementary Table 4 and Supplementary Fig. 4 online) and created an HPLC profile similar to that of the cclAD,stcJD double mutant (Fig. 1a) .
We next determined whether increased production of compounds 9-14 was reflected in gene expression in cclAD. We observed upregulated gene expression in cclAD from AN10021 through AN10023, two © 2009 Nature America, Inc. All rights reserved. (9) and emodin analogs (10) (11) (12) (13) (14) .
exceptions being AN0147 and AN10035, which expressed equally well in the control strain (Fig. 1c ). An examination of histone H3 methylation and acetylation in cclAD by chromatin immunoprecipitation of two cluster genes (AN0148 and AN10049) and one flanking gene (AN10039) indicated a strong reduction of H3K4me2 and H3K4me3 in all three genes confirming the role of the putative COMPASS member CclA in lysine 4 methylation of H3 ( Fig. 1c and Supplementary Fig. 1 ). Notably, reduced amounts of H3K4me2/3 also resulted in low levels of H3K9me2/3, a chromatin mark associated with gene silencing and heterochromatin formation, in the two genes belonging to the cluster but not in the flanking, non-expressed gene in cclAD. Thus, strongly reduced amounts of H3K4me2/3 as well as H3K9me2/3 at the 5¢ end of cluster genes are required for derepression during secondary metabolism. We hypothesize that this cluster of genes encodes enzymes or regulatory proteins required for monodictyphenone and emodin production and name them mdpAmdpL. AN10039 and AN0153 may represent boundaries of this gene cluster allowing us to propose a likely pathway ( Fig. 1d and Supplementary Fig. 3 ). Finally, we asked whether CclA regulation extended to other clusters. Notably, two anti-osteoporosis yellow polyketides, F9775B (17) and F9775A (18) , isolated from Paecilomyces carneus 22 could also be detected from the cclAD strain grown on YAG solid medium after acidified extraction (Fig. 2a,b and Supplementary Table 5 online). Disruption of the nonreducing polyketide synthase AN7909 resulted in the loss of F9775B and F9775A (Fig. 2a) . AN7909 is located in a cluster of genes 0.21 Mb from the left telomere of the 1.44 Mb chromosome II (Supplementary Table 1 ). A comparison of gene expression between cclAD and a wild-type control in this region confirmed CclA regulation of the F9775 cluster (Fig. 2c) . AN7909 and at least some of the contiguous genes (AN7910-AN7915) are predicted to be necessary for F9775 biosynthesis based on our analysis.
Sequencing of Aspergilli genomes 1 and those of several other ascomycete genera 23, 24 has exposed a wealth of SM genes, conveniently arranged in clusters, thought to aid the fungus in competing with other organisms in its natural habitat 2 . A literature survey of 1,500 fungal metabolites isolated and characterized between 1993 and 2001 showed that more than half of these molecules had antibacterial, antifungal or antitumor activity 25 . A few of these metabolites have translated into highly profitable pharmaceuticals including antibiotics, cholesterol-lowering agents, tumor inhibitors and immunosuppressants for transplant operations.
A major impediment in identifying these metabolites is finding the conditions in which they are produced. SM gene clusters are frequently silent, and efforts to elicit expression in wild-type strains have often proved futile. Recent technological advances, such as overexpressing pathway-specific transcription factors 4 , does not work to activate all SM gene clusters, nor do all clusters (for example, F9775) contain transcription factors. We present here an approach to find and collect fungal metabolites by exploiting the concept of a chromatin landscape composed of silent natural product biosynthesisrelated gene islands that can be conveniently manipulated to active chromatin states.
We hypothesized that silencing of SM gene clusters could be reversed by removing genes important in the establishment of a repressive chromatin configuration. We tested this hypothesis by removing from the A. nidulans genome the ortholog of S. cerevisiae Bre2, which had been shown to be required in yeast to silence a marker gene inserted near the telomere 15 . Loss-of-function CclA strains allowed for expression of at least two silent A. nidulans gene clusters, one yielding the active anthraquinone constituents monodictyphenone and emodins (10) (11) (12) (13) (14) , and another the anti-osteoporosis polyketides F9775A and F9775B. The critical role for chromatin regulation by histone methylation of fungal SM cluster genes raises the possibility that epigenetic mechanisms based on histone posttranslational modifications are a general mechanism to silence fungal SM gene clusters.
Supplementary Information for
Chromatin-level regulation of biosynthetic gene clusters Figure 1 . Results of chromatin immunoprecipitation (ChIP) analysis of two genes up-regulated in the cclAΔ strain.
Supplementary Figure 2.
Thin layer chromatography of chloroform extracts from three A. nidulans strains differing only in presence of cclA and laeA.
Supplementary Figure 3.
Order of genes in the monodictyphenone gene cluster.
Supplementary Figure 4.
UV/Vis and ESI-MS in negative mode of (a) austinol (7), (b) dehydroaustinol (8), (c) monodictyphenone (9), (d) emodin (10) (e) ω-hydroxyemodin (11), (f) emodic acid (12), (g) 2-hydroxyemodin (13), (h) 2-aminoemodin (14), (i) F9775B (17), (j) F9775A (18).
Supplementary Tables
Supplementary Table 1 . Gene identities in two novel CclA regulated secondary metabolite gene clusters.
Supplementary Table 2.
Fungal strains used in this study.
Supplementary Table 3 . Primers used in this study.
Supplementary Table 4 . NMR data for compounds 10 -14 (400 and 100 MHz in DMSO-d 6 ).
Supplementary Table 5 . NMR data for compound 17 and 18 (400 and 100 MHz in DMSO-d 6 ). Table   1 ). We propose that after polyketide formation by monodictyphenone PKS (MdpG), this polyketide is subsequently hydrolyzed from the PKS by the action of the hydrolase (AN0149, MdpF) to endocrocin-9-anthrone (20) . AN0147 (MdpD) might be responsible for the oxidation of endocrocin-9-anthrone (20) to endocrocin (21) . Endocrocin (21) is likely to decarboxylate spontaneously to form emodin (10) . AN0147 (MdpD) might also oxidize emodin (10) to produce emodin analogs 11 -13. Emodin analog 14 may be derived from 13 by a transaminase activity (See Figure 1d) . It should be noticed that AN0147 (MdpD) mRNA is not up-regulated during the time course studied. The endogenous level of AN0147 is possibly enough to catalyze all oxidation steps. However, the possibility that other monooxygenases not in the monodictyphenone cluster catalyzes the monodictyphenone pathway cannot be excluded. 
Supplementary Methods

Strains
Supplementary Figure 4
Supplementary Table 1. Gene identities in two novel CclA regulated secondary metabolite gene clusters. Aspergillus fumigatus This study Supplementary Table 3 . Primers used in this study. 
TGC AGT AGG G --------------------------------------------------------------------------------------------------------------------------------------
Underlined sequences show the placement of restriction sites HindIII (Br5R) & BamHI (Br3F). Blue and red sequences are tails that anneal to the A. fumigatus pyrG fragment (AfpyrG) during fusion PCR. 
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Strains.
Supplementary Table 2 lists all of the fungal strains used for this study. Some strains are not discussed in the text but were used for sexual crosses to obtain the strains of interest. All strains were maintained as silica or glycerol stocks and were grown at 37°C on glucose minimal medium (GMM) 1 sequence and 1000 bp downstream of the stcJ coding sequence was generated by fusion PCR using the protocol of Szewczyk et al. 5 . The construct was transformed into strain TN02A7 4 using the procedures of Szewczyk et al. 5 . Four transformants were chosen and all were determined by diagnostic PCR and Southern hybridizations to have a correct replacement of stcJ with AfriboB and no heterologous integration of transforming DNA. Metabolite profiles revealed that these transformants did not produce sterigmatocystin (2) . One of these transformants, LO2026, was chosen for deletion of cclA. cclA was replaced with A. fumigatus pyroA 4 using the same approach and procedures as were used for the stcJ replacement. Four transformants were analyzed by diagnostic PCR and Southern hybridizations. All had a correct replacement of cclA with AfpyroA, but one had an additional heterologous integration. All of the three correct transformants showed similar metabolite profiles and one of them (LO2051) was used for subsequent experiments.
Deletion of polyketide synthase genes:
The aromatic nature of monodictyphenone (9), emodin (10) and related compounds (11 -14) , and F9775A (18) , and AN7909. These ten NR-PKS genes were selected because they encompass every NR-PKS in the A. nidulans genome where the products are still unknown. All ten NR-PKS were disrupted by replacement, in LO2051, with the A. fumigatus pyrG gene (AfpyrG) 6 using the same approach and procedures as for stcJ and cclA. Mutants were examined for lack of production of the compounds in question. The relevant deletants were AN0150Δ (mdpGΔ) for emodin (10) and related molecules (11 -14) , and AN7909Δ deletants for F9775A (18) and B (17) .
Diagnostic PCR of the deletant and wild type strains was performed using the external primers used in the first round of the PCR. The difference in the sizes between the gene replaced by the selective marker and the native gene allowed the determination of correct gene replacement. In cases when the sizes of both the wild-type and deletant products were similar, diagnostic PCR was performed using one of the external primers and a primer located inside the marker gene. In those cases, the deletant gave the PCR product of the expected size whereas no product was present in non-deletants.
stcJ/cclA/mdpG(AN0150) triple mutant: LO2051 was chosen for deletion of mdpG (AN0150).
mdpG was replaced with AfpyrG using the same approach and procedures as were used for the stcJ replacement. Five transformants were analyzed by diagnostic PCR. All had a correct replacement of mdpG with AfpyrG. All three correct transformants showed similar metabolite profiles and one of them (LO2149) was used for subsequent experiments.
Over expression mdpE (AN0148) mutant: LO2026 was used for over expression of mdpE (AN0148). 153 bp upstream of the start codon were replaced with AfpyrG followed by a 401 bp fragment containing the A. nidulans alcA promoter 7 using the procedure of Szewczyk et al. 5 .
stcJ/cclA/AN7909 triple mutant: LO2051 was chosen for deletion of AN7909. AN7909 was replaced with AfpyrG using the same approach and procedures as were used for the stcJ replacement. Three transformants were analyzed by diagnostic PCR. All had a correct replacement of AN7909 with AfpyrG. All three transformants showed similar metabolite profiles and one of them (LO2194) was used for subsequent experiments.
Nucleic Acid Manipulations.
The extraction of DNAs from fungi and bacteria, restriction enzyme digestion, gel electrophoresis, blotting, hybridization, and probe preparation were performed by standard methods 8 . Aspergillus DNA for diagnostic PCR was isolated using the method of Lee and Taylor (1990) 9 . RNA was extracted from Aspergillus strains by use of Trizol reagent (Invitrogen) according to the manufacturer's instructions. RNA blots were hybridized with 1 kb primers amplified by PCR for AN10039, AN10021, AN10049, AN0146, AN0147, AN0148, AN0149, AN0150, AN10022, AN10035, AN10038, AN10044, AN10023, AN0153, AN7907, AN7908, AN7909, AN7910, AN7911, AN7911, AN7912, AN7913, AN7914, AN7915, and AN7916 using primers listed on Supplementary Table 3 .
ChIP coupled to quantitative PCR analysis.
ChIP was carried out as described previously 10 . Antibodies used for ChIP were from Abcam: Fig. 1 ). Two biological repeats were performed for each condition and standard deviation was calculated upon these.
To amplify the promoter and ORF regions of AN0148, AN10039 and AN10049 the primers listed on Supplementary Table 3 were used.
Fermentation and LC/MS analysis.
Aspergillus nidulans controls and deletant strains were cultivated at 37°C on solid YAG plates at 22.5 × 10 6 spores/15 cm plate (~ 40 ml medium/plate) with required supplements. After 5 days, agar was chopped into small pieces, and the material was extracted with 50 ml of MeOH, followed by 50 ml of 1:1 CH 2 Cl 2 /MeOH, with each sonicated for 1 hr. The combined extracts were evaporated in vacuo to yield a residue, which was suspended in H 2 O (50 ml) and kV, a sheath gas flow rate at 60 arbitrary units, an auxiliary gas flow rate at 10 arbitrary units, and the ion transfer capillary temperature at 350°C.
For alcA(p) inducing conditions, 50 × 10 6 spores of strain LO2333 (Supplementary Table 2) was grown in 50 ml liquid LMM medium (15 g/l lactose instead of 10 g/l glucose in GMM medium) supplemented with pyridoxine (0.5 mg/l) at 37ºC with shaking at 200 rpm.
Cyclopentanone at a final concentration of 30 mM was added to the medium after 18 hr of inoculation. Culture medium was collected 48 hr after cyclopentanone induction by filtration and extracted with the same volume of EtOAc twice. The combined EtOAc layers were evaporated in vacuo and analyzed by HPLC-DAD-MS as described above.
Isolation and identification of secondary metabolites.
For structural elucidation, 20 YAG plates inoculated with wild-type A. nidulans were grown for 5 days at 37ºC and extracted with EtOAc as described above. The crude extract was applied to a Supplementary Table 2 ) were used to purify monodictyphenone (9), emodin and its derivatives (10 -14) as described above. The crude extract was applied to a COSMOSIL 75C 18 -OPN reverse phase gel (Nacalai USA) and eluted with H 2 O-MeCN mixtures of decreasing polarity (fraction A, 1:9, 500 ml; fraction B, 3:7, 500 ml; fraction C, 7:3, 500 ml; fraction D, 0:1, 500 ml). 
Compound identification.
All compounds were characterized mainly by NMR (Supplementary Tables 4 and 5 Table 4 Table 4 ). An upshift of C-2 from δ C 139.2 in 13 to δ C 131.8 in 14 suggests the aniline amino group locates to C-2. 2D NMR (gHMQC and gHMBC) spectral data also confirmed the assigned structure. Thus, compound 14 was identified as 2-aminoemodin.
Optical rotations were measured on a JASCO P-1010 digital polarimeter, IR spectra were recorded on a Perkin-Elmer 983G spectrophotometer. NMR spectra, detailed in supplementary data, were run on a Varian Mercury Plus 400 spectrometer, and HRESIMS spectrum was obtained on Waters LCT Premier XE electrospray time-of-flight mass spectrometer.
Compound spectral data. 
